Dibenzosuberone

• Description:

  Dibenzosuberone belongs to the family of tricyclic antidepressant drugs, commonly referred to as Tricyclic antidepressants (TCAs), and is widely used in research on migraine, tension headaches, anxiety disorders, and schizophrenia. Dibenzosuberone is also a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs), such as Amitriptyline (HY-B0527), Nortriptyline (HY-118620), Noxiptiline or Cyproheptadine (HY-B1622) [1].

• UNSPSC:

  12352005

• Hazard Statement:

  H315, H319

• Target:

  Biochemical Assay Reagents; Drug Intermediate

• Related Pathways:

  Others

• Field of Research:

  Neurological Disease

• Purity:

  99.84

• Solubility:

  DMSO : 100 mg/mL (ultrasonic)

• Smiles:

  O=C1C2=CC=CC=C2CCC3=CC=CC=C13

• Molecular Formula:

  C15H12O

• Molecular Weight:

  208.26

• Precautions:

  H315, H319

• References & Citations:

  [1]Nori V, et al. A Sustainable and Catalytic Synthesis of Dibenzosuberone[J]. ChemCatChem, 2023, 15 (14) : e202300642.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  [1210-35-1]